Skip to main content
HR 6224 111th Congress House Health Advanced technology and technological innovations Cancer Child health Drug safety, medical device, and laboratory regulation Drug therapy Drug, alcohol, tobacco use Health care coverage and access Health information and medical records Health programs administration and funding Health promotion and preventive care Long-term, rehabilitative, and terminal care Medicaid Medical education Medical research Medical tests and diagnostic methods Medicare Minority health Research administration and funding Research and development

21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act

Introduced: September 28, 2010 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 28, 2010
Referred to House Ways and Means
Sep 28, 2010
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 28, 2010
Referred to House Energy and Commerce
Sep 28, 2010
Introduced in House
 Plain-English summary Congressional Research Service

21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act - Amends the Public Health Service Act to revise provisions related to the National Cancer Program, including to require the establishment of an entity within the National Cancer Institute (NCI) to augment ongoing efforts to advance new technologies in cancer research, support the national collection of tissues for cancer research purposes, and ensure the quality of tissue collection.

Sets forth provisions governing clinical trials, including ethical and privacy standards.

Requires the Director of NCI to award grants for research on cancers with a low five-year survival rate and rare cancers.

Expands coverage of colorectal screenings and treatment, including through authorizing grants and allowing states to provide coverage under Medicaid for individuals needing treatment for colorectal cancer.

Provides for biomarkers research.

Expands coverage of tobacco cessation products under Medicaid.

Provides for coverage under Medicare for payment of routine costs of care furnished to individuals participating in cancer clinical trials, comprehensive cancer planning services, and comprehensive cancer patient treatment education services.

Requires the Commissioner of Food and Drugs to review and improve the policies, programs and activities of the Food and Drug Administration (FDA) relating to oncology products.

Requires the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to expand and intensify CDC's cancer control programs.

Provides for research on cancer survivorship related to childhood cancer and health disparities in outcomes.

Requires the Secretary to convene a Workforce Development Collaborative on Psychosocial Care During Chronic Medical Illness.

What's happening now September 28, 2010

Referred to House Ways and Means

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Democratic 1